Evolent Health Announces Fourth Quarter and Full Year 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Evolent Health (EVH) PT Lowered to $23 at Jefferies
February 27, 2019 2:04 PM ESTJefferies analyst Sean Dodge lowered the price target on Evolent Health (NYSE: EVH) to $23.00 (from $30.00) while maintaining a Buy rating.
... MoreEvolent Health (EVH) PT Lowered to $21 at Oppenheimer Following 4Q
February 27, 2019 9:42 AM ESTOppenheimer analyst Mohan Naidu lowered the price target on Evolent Health (NYSE: EVH) to $21.00 (from $31.00) while maintaining a Outperform rating following the company's 4Q earnings report. EVH reported revenue of $193M vs. consensus of $189M. Adjusted EPS was ($0.07) vs. consensus's ($0.04).
For CY19, EVH... More
Evolent Health (EVH) Misses Q4 EPS by 3c, Offers Guidance
February 26, 2019 4:19 PM ESTEvolent Health (NYSE: EVH) reported Q4 EPS of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $193.3 million versus the consensus estimate of $188.74 million.
GUIDANCE:
Evolent Health sees Q1 2019 revenue of $188-197 million, versus the consensus of... More
